Of note, expression of the BAF53A paralogue is retained in CRPC-NE, pointing to potential differences in the way SWI/SNF complexes assemble in post-mitotic neurons and in neuroendocrine cancer cells, and to possible co-existence of different forms of the complex within the same tumor. This evidence concerns the gene SMARCA1 and neuroendocrine carcinoma.